Intervention Review

Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults

  1. Janet Darbyshire1,*,
  2. Mary Foulkes2,
  3. Richard Peto3,
  4. William Duncan4,
  5. Abdel Babiker1,
  6. Rory Collins5,
  7. Mike Hughes6,
  8. Tim EA Peto7,
  9. Sarah A Walker8

Editorial Group: Cochrane HIV/AIDS Group

Published Online: 24 JUL 2000

Assessed as up-to-date: 5 MAR 2000

DOI: 10.1002/14651858.CD002038


How to Cite

Darbyshire J, Foulkes M, Peto R, Duncan W, Babiker A, Collins R, Hughes M, Peto TEA, Walker SA. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults. Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD002038. DOI: 10.1002/14651858.CD002038.

Author Information

  1. 1

    London, UK

  2. 2

    FDA/CBER/OCD, Division of Biostatistics and Epidemiology, Rockville, USA

  3. 3

    University of Oxford, Clinical Trial Service and Epidemiological Studies Unit, Oxford, UK

  4. 4

    NIH, Division of AIDS, Therapeutics Research, Bethesda, USA

  5. 5

    ICRF Clinical Trial Service Unit, Oxford, UK

  6. 6

    Harvard School of Public Health, Department of Biostatistics, Boston, USA

  7. 7

    John Radcliffe Hospital, The Nuffield Department of Medicine, Oxford, UK

  8. 8

    MRC Clinical Trials Unit, HIV Division, London, UK

*Janet Darbyshire, MRC Clinical Trials Unit, 222 Euston Road, London, NW1 2DA, UK. j.darbyshire@ctu.mrc.ac.uk.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 24 JUL 2000

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. Bermúdez-Tamayo, J.J. Martín-Martín, I. Ruiz-Pérez, Años de vida ajustados por discapacidad de las personas con infección por el VIH/sida usuarias de drogas por vía parenteral, Trastornos Adictivos, 2009, 11, 1, 44

    CrossRef

  2. 2
    George W. Rutherford, Increasing the number of drugs in antiretroviral therapy may improve survival in people with HIV infection, Evidence-based Healthcare, 2002, 6, 4, 163

    CrossRef

  3. 3
    Eliza Humphreys, Lisa B. Hernandez, George Rutherford, Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy, The Cochrane Library,